Image

Global Cell Therapy Market – Industry Trends and Forecast to 2030

Healthcare

Image

Global Cell Therapy Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Cell Therapy Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 14,892.00 USD Million
Diagram Market Size (Forecast Year) USD 60,696.42 USD Million
Diagram CAGR %

Major Markets Players

  • Vericel Corporation
  • Kolon TissueGene
  • JCR Pharmaceuticals Co.
  • MEDIPOST
  • Osiris

Global Cell Therapy Market, By Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, Three-Dimensional Technology), Type (Autologous, Allogeneic), Cell Type (Stem Cell and Non-Stem Cell), Cell Source (iPSCs, Bone Marrow, Umbilical Cord Blood-Derived Cells, Adipose Tissues, Neural Stem Cell), Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Wounds and Injuries, Ocular, Others), End-User (Hospitals and Clinics, Regenerative Medicine Centres, Diagnostic and Research Centres, Others) – Industry Trends and Forecast to 2030.

Cell Therapy Market

Cell Therapy Market Analysis and Size

The incidence of cell therapy can vary depending on several factors, including the availability and approval status of cell therapies, the specific indications or diseases being treated, and the healthcare infrastructure and resources in a given area. Cell therapy is a rapidly evolving field, and the incidence of cell therapy treatments is expected to increase as more therapies receive regulatory approval and become commercially available. However, it is important to note that the incidence may still be relatively low compared to more established treatment modalities, as cell therapies are often complex, personalized, and may still be in the early stages of adoption.

Data Bridge Market Research analyses that the global cell therapy market which was USD 14,892.00 million in 2022, is expected to reach USD 60,696.42 million by 2030, and is expected to undergo a CAGR of 19.2% during the forecast period of 2023 to 2030. “Cell Immortalization Technology" dominates the technology segment of the global cell therapy market owing to the growing demand for better cell and tissue therapy methods for treatment of chronic disorders. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Cell Therapy Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, and Pricing in USD

Segments Covered

Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, Three-Dimensional Technology), Type (Autologous, Allogeneic), Cell Type (Stem Cell and Non-Stem Cell), Cell Source (iPSCs, Bone Marrow, Umbilical Cord Blood-Derived Cells, Adipose Tissues, Neural Stem Cell), Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Wounds and Injuries, Ocular, Others), End-User (Hospitals and Clinics, Regenerative Medicine Centres, Diagnostic and Research Centres, Others)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

Vericel Corporation (U.S), Kolon TissueGene Inc. (U.S), JCR Pharmaceuticals Co. Ltd. (Jpana), MEDIPOST (South Korea), Osiris (U.S), Stemedica Cell Technologies Inc. (U.S), NuVasive Inc. (U.S), Fibrocell Science Inc. (U.S), Cellectis (France), BioNTech IMFS (Germany), Pluristem (Israel), Praxis Pharmaceutical (U.S), Genzyme Corporation (U.S), Advanced Tissue (U.S), Cells for Cells (Chile), PHARMICELL Co. Ltd (South Korea), ANTEROGEN.CO.LTD. (South Korea), Novartis AG (Switzerland), GlaxoSmithKline plc (U.K), CELGENE CORPORATION (U.S), Bone Therapeutics (Belgium), Cell Therapies (U.K), Celyad (Belgium), Regen BioPharma (U.S), Cellular Therapeutics Ltd (China), TxCell (France), Advancells (India)

Market Opportunities

  • An Increase in R&D activities
  • The strategic initiatives by market players

Market Definition

Cell therapy is a technology that relies on replacing diseased or dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, owing to their ability to differentiate into specific cells required for repairing damaged or defective tissues or cells.

Cell therapy finds its application in development of regenerative medicines, which is a multidisciplinary area aimed at maintenance, improvement, or restoration of cell, tissue, or organ function using methods mainly related to cell therapy.

Global Cell Therapy Market Dynamics

Drivers

  • The Rise in Prevalence and Incidence of Chronic Diseases

The majority of people around the world suffer from chronic ailments. One in three adults worldwide has a chronic illness. Chronic diseases have impacted the health and quality of life of many people. Chronic illnesses, such as cancer, musculoskeletal and neurological conditions, chronic injuries, cardiovascular and gastrointestinal conditions, and cancer, can result in hospitalization, long-term incapacity, declining quality of life, and even death.

The mesenchymal stem cells penetrate and integrate into several organs, treat lung, spinal cord, autoimmune disorders, liver, bone, and cartilage diseases, and multiple organ damage. Using stem cells in treating the inflammatory, immune system, and degenerative tissue illnesses is an effective strategy. These are certain factors that propel the growth of the market.

  • The Growing Need for Potent Treatments

One of the key drivers of market expansion is significant R&D investments. In addition, the growing need for potent treatments to reduce disease burden during the forecast period is another factor fueling the growth. For instance, the 5-year exploratory study on Parkinson's illness by Celavie Biosciences is ongoing as of May 2020. For the treatment of Parkinson's disease and other illnesses of the central nervous system, the business is developing regenerative stem cell therapies. Ok99 stem cell-based exploratory clinical studies for Parkinson's disease were effective, according to Celavie Biosciences. These are certain factors that propel the growth of the market.

Opportunities

  • An Increase in R&D Activities

The increase in R&D activities and rising investments from public and private organizations will open up new possibilities for the market's growth rate. For instance, U.S. healthcare spending increased by 3.4% in 2021, per the Health Care Price Index (HCPI). The rise in growth indicates that federal spending fell sharply the year before, from USD 287,000 million in 2020 to USD 170,000 million in 2021.

The prompt treatment of chronic illnesses has increased the demand for stem cell therapy in the U.S. and Europe. Due to these positive elements, there is a greater need for drugs, and both major and minor market players are employing various techniques to meet this demand. This factor is expected to boost market growth.

  • The Strategic Initiatives by Market Players

The leading companies are also working to develop targeted strategies, including product launches, acquisitions, approvals, expansions, and partnerships, to ensure the smooth operation of the business, minimize risks, and boost the market's long-term growth in sales. This factor is expected to boost the market growth.

Restraints/Challenges

  • High Cost Associated with the Treatment

Global cell therapy treatment market expansion has been hampered by its high cost. As people search for the newest therapy choices, cell treatments have emerged as a popular treatment option. Despite the enormous rise in demand for cell therapy, treatments are still exceedingly expensive. Depending on the situation, simple joint injections might cost up to $1,000, and more complex operations can cost up to $100,000. In the U.S., the average price of stem cell therapy will be between $4,000 and $8,000 per patient in 2020. Therefore, the growth of the cell therapy market is restrained by the high cost of the treatment.

  • Supply Chain and Logistics

Cell therapies require specialized infrastructure and expertise for handling, storage, and transportation. Maintaining the integrity and viability of cells throughout the supply chain can be challenging, especially for therapies with short shelf lives or those that require cryopreservation.

This global cell therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cell therapy market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

  • In December 2021, Century Therapeutics, a biotechnology company, collaborated with Bristol Myers Squibb, a pharmaceutical company, and signed a license agreement to develop and commercialize up to four induced pluripotent stem cell ("iPSC") derived, engineered natural killer cell ("iNK") and T cell ("iT") programs for hematologic malignancies and solid tumors

Global Cell Therapy Market Scope

The global cell therapy market is segmented on the basis of technology, type, cell type, cell source, application, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technology

 Type

  • Autologous
  • Allogeneic

Cell Type

  • Stem Cell
  • Non-Stem Cell

Cell Source

  • iPSCs
  • Bone Marrow
  • Umbilical Cord Blood-Derived Cells
  • Adipose Tissues
  • Neural Stem Cell

Application

  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Wounds and Injuries
  • Ocular
  • Others

End User

  • Hospitals and Clinics
  • Regenerative Medicine Centres
  • Diagnostic and Research Centres
  • Others

Global Cell Therapy Market Regional Analysis/Insights

The global cell therapy market is analysed and market size insights and trends are provided by country, technology, type, cell type, cell source, application, and end-user as referenced above.

The countries covered in the global cell therapy market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.

North America dominates the global cell therapy market because of its strong base of healthcare facilities, the strong presence of major players, the extraordinary healthcare infrastructure, and the large pool of people suffering from chronic disorders.

Asia-Pacific is expected to witness significant growth in the global cell therapy market during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for chronic ailment treatments, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global cell therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global cell therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global cell therapy market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Cell Therapy Market Share Analysis

The global cell therapy market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global cell therapy market.

Some of the major players operating in the global cell therapy market are:

  • Vericel Corporation (U.S)
  • Kolon TissueGene Inc. (U.S)
  • JCR Pharmaceuticals Co. Ltd. (Japan)
  • MEDIPOST (South Korea)
  • Osiris (U.S)
  • Stemedica Cell Technologies Inc. (U.S)
  • NuVasive Inc. (U.S)
  • Fibrocell Science Inc. (U.S)
  • Cellectis (France)
  • BioNTech IMFS (Germany)
  • Pluristem (Israel)
  • Praxis Pharmaceutical (U.S)
  • Genzyme Corporation (U.S)
  • Advanced Tissue (U.S)
  • Cells for Cells (Chile)
  • PHARMICELL Co. Ltd (South Korea)
  • ANTEROGEN.CO.LTD. (South Korea)
  • Novartis AG (Switzerland)
  • GlaxoSmithKline plc (U.K)
  • CELGENE CORPORATION (U.S)
  • Bone Therapeutics (Belgium)
  • Cell Therapies (U.K)
  • Celyad (Belgium)
  • Regen BioPharma (U.S)
  • Cellular Therapeutics Ltd (China)
  • TxCell (France)
  • Advancells (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Cell Therapy Market will be worth USD 60,696.42 million by 2030.
The Cell Therapy Market growth rate is 19.2% during the forecast period.
The Rise in Prevalence and Incidence of Chronic Diseases & Growing Need for Potent Treatments are the growth drivers of the Cell Therapy Market.
The technology, type, cell type, cell source, application, and end-user are the factors on which the Cell Therapy Market research is based.
Century Therapeutics, a biotechnology company, collaborated with Bristol Myers Squibb, a pharmaceutical company, and signed a license agreement to develop and commercialize up to four induced pluripotent stem cell ("iPSC") derived, engineered natural killer cell ("iNK") and T cell ("iT") programs for hematologic malignancies and solid tumors is the latest developments in the Cell Therapy Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials